Hepatitis B Virus Status and Risk of Pancreatic Ductal Adenocarcinoma: A Case-Control Study From China
Pancreas, 03/21/2012Ben Q et al.
The results suggest that hepatitis B surface antigen (HBsAg)–positive or anti–HBc–positive/anti–HBs–negative patients have an increased risk for pancreatic ductal adenocarcinoma (PDAC) independent of other risk factors. Significant interactions were found between a history of diabetes mellitus (DM) and chronic hepatitis B virus (HBV) infection for PDAC risk.
MDLinx connects healthcare professionals and patients to tomorrow's important medical news, while providing the pharmaceutical and healthcare industries with highly targeted interactive marketing, education, content, and medical research solutions.